KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Navaneethan S, Bansal N, Cavanaugh K, Chang A, Crowley S, Delgado C, Estrella M, Ghossein C, Ikizler T, Koncicki H, St Peter W, Tuttle K, William J. KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. American Journal Of Kidney Diseases 2024 PMID: 39556063, DOI: 10.1053/j.ajkd.2024.08.003.Peer-Reviewed Original ResearchKidney Disease Outcomes Quality InitiativeChronic kidney diseaseManagement of chronic kidney diseaseKDIGO guidelinesTeam-based careContext of clinical practiceChronic kidney disease burdenEarly identification of CKDWorking GroupClinical practice guidelinesIdentification of chronic kidney diseaseKidney diseaseSodium/glucose cotransporter 2 inhibitorsGlucagon-like peptide 1 receptor agonistsNonsteroidal mineralocorticoid receptor antagonistChronic kidney disease etiologyPeptide 1 receptor agonistsManaging kidney diseaseChronic kidney disease evaluationMineralocorticoid receptor antagonistsSlow CKD progressionImprove cardiovascular outcomesEvidence basePractice guidelinesCKD-related complications